17 winners chosen from over 250 entries, with Nanobiotix winning both ‘CEO‘ and ‘Pharma Company of the Year’ categories
The 2018 CPhI Pharma Award winner by category:
- Excellence in Pharma: API Development – Artemisinin, Ipca Labs Limited
Excellence in Pharma: Formulation – Micelle Inside Solubilisation, MiVital AG
Excellence in Pharma: Excipients – Parteck® MXP Excipient, Merck
Excellence in Pharma: Manufacturing Technology and Equipment – AqVida filling line, AqVida GmbH
Excellence in Pharma: Bioprocessing & Manufacturing – Simplification of Fed-Batch Processes Using Modified Amino Acids, Merck
Excellence in Pharma: Analysis, Testing, and Quality Control – HyperFlux™ PRO Plus, Tornado Spectral Systems
Excellence in Pharma: Drug Delivery Devices – e-NOVELIA, the smart ophthalmic add-on,
Nemera. Highly commended – IQ-Dose, Stiplastics
Excellence in Pharma: Packaging – Dual-Mix®, TECHNOFLEX. Highly commended – QuickFlip™, Aptar Pharma
Excellence in Pharma: Supply Chain, Logistics & Distribution – UniSecure®, Systech International
Excellence in Pharma: Contract Services & Outsourcing – Development of a novel bio-catalysed manufacturing route for a generic API, CatSci Ltd. Highly commended – Continuous Flow Centre of Excellence, Cambrex
Excellence in Pharma: Regulatory and Compliance Framework, COMPLi– Scientist.com
Excellence in Pharma: Corporate Social Responsibility – Delivering on the Promise of Good Corporate Citizenship, West Pharmaceutical Services, Inc.
Excellence in Pharma: CEO of the Year – Laurent Levy, Nanobiotix
Excellence in Pharma: Pharma Company of the Year – Nanobiotix
Excellence in Pharma: OTC – Excilor 2-in-1 Wart Treatment Device, Medical Brands and Vemedia
Excellence in Pharma: Patient Centricity – SRS Unistraw Delivery System, SRS Life Sciences Pte Ltd
Excellence in Pharma: IT, mHealth & Digitalisation – Qualit-e Cloud, Qualit-e Cloud GmbH
Madrid, 10 October 2018: CPhI Worldwide, organised by UBM (part of Informa PLC), announces the winners of the prestigious 2018 CPhI Pharma Awards. The awards, in their 15th edition, welcomed 365 guests last night to celebrate outstanding achievements in pharma across 17 different categories.
The winner of the award for ‘API Development’ was Ipca Labs Limited for Artemisinin, a new process development that lowers the cost of production to US$100 per kilogramme. The ‘Formulation’ award was given to MiVital AG for its new bioavailability technology, which works by encapsulating lipophilic compounds, making them soluble in an aqueous environment.
Merck received the ‘Excipients’ prize for their Parteck® MXP Excipient that increases the solubility of poorly soluble APIs, so that they can reach a supersaturated dissolution state.
The ‘Manufacturing Technology and Equipment’ award was given to AqVida GmbH for the AqVida filling line – a commercial-scale filling line with robotic arms that saves costs and reduces human interaction.
Merck received a second award for ‘Bioprocessing’ in recognition of its Simplification of Fed-Batch Processes Using Modified Amino Acids. This breakthrough allows for a single, neutral pH feed and results in a more efficient and stable process.
The prestigious ‘CEO of the Year’ award has been presented to Laurent Levy, PhD, the founder and CEO of Nanobiotix who has propelled the company to the forefront of oncological nanomedicine development. Yet the commendations did not stop there with Nanobiotix receiving the award for ‘Pharma Company of the Year’. The company is pioneering new approaches in cancer treatment and fast becoming the leading nanomedicine company.
Tornado Spectral Systems was successful in the ‘Analysis, Testing, and Quality Control’ category for the HyperFlux™ PRO Plus, which permits faster and more sensitive process measurements and enhances spectral throughput.
Nemera received the ‘Drug Delivery Devices’ prize for e-NOVELIAt he smart ophthalmic add-on – it assists in drug delivery and reminds patients when to take their dosage.
TECHNOFLEX won in the ‘Packaging’ category for its Dual-Mix® bag that allows for quicker and safer drug reconstitution. In ‘Supply Chain, Logistics, and Distribution’ Systech International has been commended for its UniSecure® – a supply chain innovation that uses packaging barcodes to create a digital e-fingerprint for product protection.
The ‘Contract Services and Outsourcing’ award was given to CatSci for the development of a novel bio-catalysed manufacturing route for a generic API, enabling accelerated drug development timelines and lower costs for pharma companies.
Scientist.com was chosen as the winner of the ‘Regulatory Procedures and Compliance’ award in recognition of its new regulatory and compliance framework, COMPLi.
West Pharmaceutical Services, Inc was granted the ‘Corporate Social Responsibility’ award for delivering good corporate citizenship – particularly its recent achievements in environmental sustainability.
Medical Brands & Vemedia was victorious in the ‘OTC’ category for its Excilor 2-in-1 Wart Treatment Device. This is a single streamlined device combining cryo technology and an acid based on TCA-Active.
In the ‘Patient Centricity’ category, SRS Life Sciences won thanks to the Unistraw Delivery System, a child focussed approach to pharmaceuticals and supplements delivery.
Qualit-e Cloud GmbH received the ‘IT, mHealth & Digitilisation’ award for its new web portal. This innovation enables pharmaceutical raw material producers to upload their quality documents and authorise customers and distributors to download.
Tara Dougal, Head of Content – Pharma at UBM, added: “This year has been a truly remarkable and record-breaking year for the pharmaceutical industry and this was definitely mirrored in the extremely high standard of entries at the CPhI Pharma Awards. In our 15th year, we have seen a staggering number of submissions across the pharmaceutical supply chain.
The judges have meticulously assessed each of the entries over all 17 categories and have selected extremely worthy winners. Exemplifying just how difficult a choice it has been – there were too many exceptional entries – the judges felt the need to highly commend several other additional finalists.
On behalf of CPhI Worldwide and UBM, I would like to thank each entrant and sincerely congratulate this year’s winners.”
For more information on the CPhI Pharma Awards please visit: http://awards.cphi.com/
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, North America, and the Middle East and Africa. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; BioPh for biopharma; and Finished Dosage Formulation for every aspect of the finished dosage supply chain. CPhI provides an online buyer and supplier directory at CPhI-Online.com. For more information visit https://www.cphi.com
About UBM (and parent company Informa)
CPhI is organised by UBM, which in June 2018 combined with Informa PLC to become a leading B2B information services group and the largest B2B Events organiser in the world. To learn more and for the latest news and information, visit www.ubm.comand www.informa.com